We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$46.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.34B
Cap. Flow %
5.06%
Top 10 Hldgs %
17.9%
Holding
3,541
New
248
Increased
1,836
Reduced
1,143
Closed
207

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Healthcare 9.23%
3 Financials 8.81%
4 Industrials 6.85%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UDR icon
1901
UDR
UDR
$12.3B
$1.19M ﹤0.01%
30,646
+5,577
+22% +$212K
NNN icon
1902
NNN REIT
NNN
$8.94B
$1.19M ﹤0.01%
30,486
-310
-1% -$12.5K
TECH icon
1903
Bio-Techne
TECH
$11.2B
$1.19M ﹤0.01%
40,568
-360
-0.9% -$9.84K
AHRT
1904
AH Realty Trust
AHRT
$515M
$1.19M ﹤0.01%
91,954
+36,827
+67% +$504K
DSM
1905
BNY Mellon Strategic Municipal Bond Fund
DSM
$291M
$1.19M ﹤0.01%
139,926
+2,559
+2% +$21.6K
ETG
1906
Eaton Vance Tax-Advantaged Global Dividend Income Fund
ETG
$1.84B
$1.19M ﹤0.01%
69,780
+2,941
+4% +$48.7K
EWO icon
1907
iShares MSCI Austria ETF
EWO
$186M
$1.19M ﹤0.01%
+56,046
New +$1.13M
ABG icon
1908
Asbury Automotive
ABG
$3.88B
$1.19M ﹤0.01%
+21,009
New +$1.21M
PCRX icon
1909
Pacira BioSciences
PCRX
$1.02B
$1.19M ﹤0.01%
24,845
+14,307
+136% +$664K
CCLP
1910
DELISTED
CSI Compressco LP
CCLP
$1.19M ﹤0.01%
244,240
-13,114
-5% -$88.4K
STL
1911
DELISTED
Sterling Bancorp
STL
$1.18M ﹤0.01%
50,925
+7,007
+16% +$160K
CZR
1912
DELISTED
Caesars Entertainment Corporation
CZR
$1.18M ﹤0.01%
98,515
+44,820
+83% +$501K
PTMC icon
1913
Pacer Trendpilot US Mid Cap ETF
PTMC
$400M
$1.18M ﹤0.01%
41,613
+7,715
+23% +$216K
ACOR
1914
DELISTED
Acorda Therapeutics
ACOR
$1.18M ﹤0.01%
+500
New +$991K
UGI icon
1915
UGI
UGI
$7.35B
$1.18M ﹤0.01%
24,369
+4,226
+21% +$210K
AR icon
1916
Antero Resources
AR
$10.7B
$1.18M ﹤0.01%
54,443
-37,303
-41% -$800K
TREE icon
1917
LendingTree
TREE
$447M
$1.18M ﹤0.01%
6,832
-3,642
-35% -$548K
OTIC
1918
DELISTED
Otonomy, Inc.
OTIC
$1.18M ﹤0.01%
62,339
-461
-0.7% -$6.43K
GLAD icon
1919
Gladstone Capital
GLAD
$441M
$1.17M ﹤0.01%
59,496
+115
+0.2% +$2.25K
NS
1920
DELISTED
NuStar Energy L.P.
NS
$1.17M ﹤0.01%
25,026
-1,997
-7% -$93.4K
AGD
1921
abrdn Global Dynamic Dividend Fund
AGD
$318M
$1.17M ﹤0.01%
113,902
+80,567
+242% +$811K
AMZA icon
1922
InfraCap MLP ETF
AMZA
$470M
$1.17M ﹤0.01%
11,538
-866
-7% -$88.5K
SPH icon
1923
Suburban Propane Partners
SPH
$1.18B
$1.17M ﹤0.01%
48,983
+614
+1% +$15.2K
IGM icon
1924
iShares Expanded Tech Sector ETF
IGM
$10.6B
$1.16M ﹤0.01%
48,234
-234
-0.5% -$5.62K
VONE icon
1925
Vanguard Russell 1000 ETF
VONE
$8.52B
$1.16M ﹤0.01%
10,458
+1,591
+18% +$175K

Similar funds

Raymond James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.

  • Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
  • Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
  • Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
  • Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
  • Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.